Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency
NCT05586737
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Diseases
Premature Ovarian Insufficiency
Interventions
DRUG:
Rituximab
Sponsor
Angelica Lindén Hirschberg